Go to main contents

International Cooperation

Global Network

UPDATE
2022-06-24
SHARE 링크연결 공유 인쇄

Statens Serum Institut of Denmark, U.S. National Institute of Allergy and Infectious Diseases, U.S. Moderna, UN International Vaccine Institute, Leibniz Institute DSMZ

Statens Serum Institut of Denmark (SSI)

Partnership commencement date : 2021. 6. 28.

Responsible team : Division of Infectious Diseases Research Planning

What we do in partnership

  • Strengthening mutual cooperation for sharing vaccine production information, including each institution’s roles in vaccine development, vaccine development and progress in research, and Mix and match vaccination issues in order to ensure safe and effective development and supply of COVID-19 vaccines

Statens Serum Institut of Denmark (SSI)

U.S. National Institute of Allergy and Infectious Diseases (NIAID)

Partnership commencement date : 2021. 5. 18.

Responsible team : Division of Vaccine Clinical Research

What we do in partnership

  • Exchanging expression of interest (EOI) letters for research cooperation in vaccines and medications
  • Prioritizing research in vaccine development and medications for new infectious diseases, including COVID-19
  • Planning to conduct research on vaccines and medications for tuberculosis, antibiotic resistance, and immunology of infectious diseases.

Institute of Allergy and Infectious Diseases (NIAID)

U.S. Moderna

Partnership commencement date : 2021. 5. 22.

Responsible team : Division of Infectious Disease Vaccine Research

What we do in partnership

  • mRNA vaccine research cooperation for COVID-19 and infectious diseases of mutual interest

Moderna

UN International Vaccine Institute (IVI)

Partnership commencement date : 2012. 7. 20.

Responsible team : Division of Vaccine Development Coordination

What we do in partnership

  • Creating synergies through mutual cooperation for vaccine research

International Vaccine Institute(IVI)

Leibniz Institute DSMZ

Partnership commencement date : 2011. 11. 28.

Responsible team : Division of Pathogen Resource Management

What we do in partnership

  • Building an organic network for the exchange and research of microbial resources, including pathogens

Leibniz Institute DSMZ-Geran Collention of Microorganisms and Cell Cultures GmbH

KOGL, Korea Open Government License, BY, NC, NDType 4 : Source Indication - Commercial Use Prohibition - Change Prohibition The works of the Ministry of Science and ICT can be used under the terms of "KOGL Type 4".
connect